China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
The drug has so far been authorized in about 40 countries including the United States and Israel, while the European Union has permitted member states to use it ahead of formal approval as an emergency measure against the rapidly spreading Omicron variant, according to AFP.
